Yuyu Pharma Inc. Pfd. Series 2
Yuyu Pharma Inc. Pfd. Series 2 operates in Diversified Metals & Mining.
Market Cap & Net Worth: Yuyu Pharma Inc. Pfd. Series 2 (000227)
Yuyu Pharma Inc. Pfd. Series 2 (KQ:000227) has a market capitalization of $71.72K (₩105.01 Million) as of March 19, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #41791 globally and #2306 in its home market, demonstrating a 4.99% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Yuyu Pharma Inc. Pfd. Series 2's stock price ₩10730.00 by its total outstanding shares 9787 (9.79K).
Yuyu Pharma Inc. Pfd. Series 2 Market Cap History: 2015 to 2026
Yuyu Pharma Inc. Pfd. Series 2's market capitalization history from 2015 to 2026. Data shows growth from $55.51K to $71.72K (1.61% CAGR).
Yuyu Pharma Inc. Pfd. Series 2 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Yuyu Pharma Inc. Pfd. Series 2's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 000227 by Market Capitalization
Companies near Yuyu Pharma Inc. Pfd. Series 2 in the global market cap rankings as of March 19, 2026.
Key companies related to Yuyu Pharma Inc. Pfd. Series 2 by market ranking:
- BERKSHIRE HATH-A (BE:BRH): Ranked #2328 globally with a market cap of $6.43 Billion USD ( €6.27 Billion EUR).
- BERKSHIRE HATH-A - Dusseldorf Stock Exchang (DU:BRH): Ranked #2395 globally with a market cap of $6.17 Billion USD ( €6.02 Billion EUR).
- Itissalat Al-Maghrib (IAM) S.A (PINK:MAOTF): Ranked #3760 globally with a market cap of $3.25 Billion USD.
- NET ONE SYSTEMS (MU:NOX): Ranked #4660 globally with a market cap of $2.24 Billion USD ( €2.18 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #2328 | BERKSHIRE HATH-A | BE:BRH | $6.43 Billion | €634500.00 |
| #2395 | BERKSHIRE HATH-A - Dusseldorf Stock Exchang | DU:BRH | $6.17 Billion | €638000.00 |
| #3760 | Itissalat Al-Maghrib (IAM) S.A | PINK:MAOTF | $3.25 Billion | $14.80 |
| #4660 | NET ONE SYSTEMS | MU:NOX | $2.24 Billion | €1000000.00 |
Yuyu Pharma Inc. Pfd. Series 2 Historical Marketcap From 2015 to 2026
Between 2015 and today, Yuyu Pharma Inc. Pfd. Series 2's market cap moved from $55.51K to $ 71.72K, with a yearly change of 1.61%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩71.72K | -4.03% |
| 2025 | ₩74.73K | +16.70% |
| 2024 | ₩64.03K | -21.99% |
| 2023 | ₩82.08K | -17.66% |
| 2022 | ₩99.68K | -15.78% |
| 2021 | ₩118.37K | +8.74% |
| 2020 | ₩108.85K | +78.31% |
| 2019 | ₩61.05K | +10.27% |
| 2018 | ₩55.36K | -6.34% |
| 2017 | ₩59.11K | +53.13% |
| 2016 | ₩38.60K | -30.45% |
| 2015 | ₩55.51K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Yuyu Pharma Inc. Pfd. Series 2 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $71.72K USD |
| MoneyControl | $71.72K USD |
| MarketWatch | $71.72K USD |
| marketcap.company | $71.72K USD |
| Reuters | $71.72K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.